Literature DB >> 24307588

High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.

Christopher J A Duncan1, James P Williams, Torben Schiffner, Kathleen Gärtner, Christina Ochsenbauer, John Kappes, Rebecca A Russell, John Frater, Quentin J Sattentau.   

Abstract

Macrophage infection is considered to play an important role in HIV-1 pathogenesis and persistence. Using a primary cell-based coculture model, we show that monocyte-derived macrophages (MDM) efficiently transmit a high-multiplicity HIV-1 infection to autologous CD4(+) T cells through a viral envelope glycoprotein (Env) receptor- and actin-dependent virological synapse (VS), facilitated by interactions between ICAM-1 and LFA-1. Virological synapse (VS)-mediated transmission by MDM results in high levels of T cell HIV-1 integration and is 1 to 2 orders of magnitude more efficient than cell-free infection. This mode of cell-to-cell transmission is broadly susceptible to the activity of CD4 binding site (CD4bs) and glycan or glycopeptide epitope-specific broadly neutralizing monoclonal antibodies (bNMAbs) but shows resistance to bNMAbs targeting the Env gp41 subunit membrane-proximal external region (MPER). These data define for the first time the structure and function of the macrophage-to-T cell VS and have important implications for bNMAb activity in HIV-1 prophylaxis and therapy. IMPORTANCE The ability of HIV-1 to move directly between contacting immune cells allows efficient viral dissemination with the potential to evade antibody attack. Here, we show that HIV-1 spreads from infected macrophages to T cells via a structure called a virological synapse that maintains extended contact between the two cell types, allowing transfer of multiple infectious events to the T cell. This process allows the virus to avoid neutralization by a class of antibody targeting the gp41 subunit of the envelope glycoproteins. These results have implications for viral spread in vivo and the specificities of neutralizing antibody elicited by antibody-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307588      PMCID: PMC3911534          DOI: 10.1128/JVI.03245-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

Authors:  Michael S Seaman; Holly Janes; Natalie Hawkins; Lauren E Grandpre; Colleen Devoy; Ayush Giri; Rory T Coffey; Linda Harris; Blake Wood; Marcus G Daniels; Tanmoy Bhattacharya; Alan Lapedes; Victoria R Polonis; Francine E McCutchan; Peter B Gilbert; Steve G Self; Bette T Korber; David C Montefiori; John R Mascola
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

Review 2.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

3.  Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages.

Authors:  Sonja Welsch; Fedde Groot; Hans-Georg Kräusslich; Oliver T Keppler; Quentin J Sattentau
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

4.  As good as it gets? The problem of HIV persistence despite antiretroviral drugs.

Authors:  Alex Sigal; David Baltimore
Journal:  Cell Host Microbe       Date:  2012-08-16       Impact factor: 21.023

5.  Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.

Authors:  Clare Jolly; Nicola J Booth; Stuart J D Neil
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

6.  Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials.

Authors:  Angela M Mexas; Erin H Graf; Matthew J Pace; Jianqing J Yu; Emmanouil Papasavvas; Livio Azzoni; Michael P Busch; Michele Di Mascio; Andrea S Foulkes; Stephen A Migueles; Luis J Montaner; Una O'Doherty
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

7.  Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy.

Authors:  Alex Sigal; Jocelyn T Kim; Alejandro B Balazs; Erez Dekel; Avi Mayo; Ron Milo; David Baltimore
Journal:  Nature       Date:  2011-08-17       Impact factor: 49.962

8.  HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.

Authors:  Gaia Vasiliver-Shamis; Michael L Dustin; Catarina E Hioe
Journal:  Viruses       Date:  2010-05-01       Impact factor: 5.048

Review 9.  Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.

Authors:  Herwig Koppensteiner; Ruth Brack-Werner; Michael Schindler
Journal:  Retrovirology       Date:  2012-10-04       Impact factor: 4.602

10.  HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse.

Authors:  Clare Jolly; Kirk Kashefi; Michael Hollinshead; Quentin J Sattentau
Journal:  J Exp Med       Date:  2004-01-19       Impact factor: 14.307

View more
  71 in total

1.  Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.

Authors:  Hongru Li; Chati Zony; Ping Chen; Benjamin K Chen
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

2.  CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.

Authors:  Tanya O Robinson; Mingce Zhang; Christina Ochsenbauer; Lesley E Smythies; Randall Q Cron
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

3.  The Multiplicity of Cellular Infection Changes Depending on the Route of Cell Infection in a Plant Virus.

Authors:  Serafín Gutiérrez; Elodie Pirolles; Michel Yvon; Volker Baecker; Yannis Michalakis; Stéphane Blanc
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 4.  Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.

Authors:  Rebecca Rose; David J Nolan; Ekaterina Maidji; Cheryl A Stoddart; Elyse J Singer; Susanna L Lamers; Michael S McGrath
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

5.  New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif.

Authors:  S Abigail Smith; Cynthia A Derdeyn
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

6.  The HIV-1 viral synapse signals human foreskin keratinocytes to secrete thymic stromal lymphopoietin facilitating HIV-1 foreskin entry.

Authors:  Z Zhou; L Xu; A Sennepin; C Federici; Y Ganor; D Tudor; D Damotte; N Barry Delongchamps; M Zerbib; M Bomsel
Journal:  Mucosal Immunol       Date:  2017-04-26       Impact factor: 7.313

Review 7.  HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy.

Authors:  Luis M Agosto; Pradeep D Uchil; Walther Mothes
Journal:  Trends Microbiol       Date:  2015-03-09       Impact factor: 17.079

Review 8.  The meningeal lymphatic system: a route for HIV brain migration?

Authors:  Susanna L Lamers; Rebecca Rose; Lishomwa C Ndhlovu; David J Nolan; Marco Salemi; Ekaterina Maidji; Cheryl A Stoddart; Michael S McGrath
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

9.  Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.

Authors:  Jingga Inlora; Vineela Chukkapalli; Sukhmani Bedi; Akira Ono
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells.

Authors:  Bin Su; Marina Elizabeth Biedma; Alexandre Lederle; Maryse Peressin; Mélanie Lambotin; Alizé Proust; Thomas Decoville; Sylvie Schmidt; Géraldine Laumond; Christiane Moog
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.